BioXcel Therapeutics, Inc. (BTAI)

1.48 -0.13 (-8.07%) USD  |  NASDAQ  |  Mar 06, 16:00
1.47 -0.01 (-0.68%) After-Hours: 20:00
More

BioXcel Therapeutics Repurchase of Capital Stock (Annual Per Share)

Repurchase of Capital Stock (Annual Per Share) Chart

View Repurchase of Capital Stock (Annual Per Share) for BTAI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Repurchase of Capital Stock (Annual Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Repurchase of Capital Stock (Annual Per Share) Range, Past 5 Years

View Repurchase of Capital Stock (Annual Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Repurchase of Capital Stock (Annual Per Share) Benchmarks

View Repurchase of Capital Stock (Annual Per Share) Benchmarks
Start Trial
Rigel Pharmaceuticals, Inc. Upgrade
Puma Biotechnology, Inc. Upgrade
Quince Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade